Tennessee's Failed Execution of Christa Pike: What Went Wrong and What Comes Next

Tennessee's attempt to execute convicted murderer Christa Pike by lethal injection has ended in failure, leaving the 50-year-old hospitalized and undergoing emergency medical treatment. The case, already the subject of a protracted legal battle, has reignited debate over capital punishment in the United States and raised troubling questions about the state's execution protocols.

Pike was sentenced to death in 1996 for the murder of 19-year-old Colleen Slemmer. The killing was carried out alongside Pike's then-boyfriend, Tadaryl Shipp. On Wednesday evening local time, after the US Supreme Court cleared the way at the eleventh hour, authorities began administering the lethal injection. Pike received two syringes of pentobarbital, a powerful sedative used in executions across several states.

According to her legal team, the drug failed to stop her heartbeat. They further stated that Pike could still be heard snoring after the second dose was administered, indicating that she remained alive. The Tennessee Department of Correction has defended its methods, stating that "the protocol does not allow for additional procedures beyond what was carried out this evening."

The state's execution protocol does not clearly specify what should be done if an inmate survives a second dose of pentobarbital, according to the AP news agency. Authorities have not yet explained why the dosage proved non-fatal, though medical experts have offered their own theories. Dr Joel Zivot, a professor at Emory University School of Medicine who was retained by Pike's legal team as a medical expert, told the BBC that Pike likely never achieved a sufficient blood level of pentobarbital to cause apnoea and cardiovascular failure.

Following the failed execution, Pike was transferred to an off-site medical facility. One of her lawyers said she is "being provided life-saving measures" in hospital. Her current health status remains unclear. Zivot cautioned that "it's very possible that as a consequence of the delay of the beginning of resuscitation she will have a brain injury."

Tennessee Governor Bill Lee has ordered a third-party review of the incident. He also announced that the state's last remaining execution scheduled for this year will not proceed as planned. The decision signals growing concern within the state about the reliability of its execution procedures.

The failed attempt has drawn sharp reactions from both supporters and opponents of the death penalty. May Martinez, the mother of Colleen Slemmer, who had pushed for Pike's execution to take place, told NBC News that the events had been "a mess." Her reaction underscores the anguish felt by victims' families when justice is delayed or derailed by procedural failures.

Opponents of capital punishment have been equally quick to respond. Maya Foa, chief executive of the international legal organization Reprieve, said: "We cannot know exactly what went wrong, because so much happened behind a curtain – lethal injection relies on secrecy at every stage, to hide the violence of the state taking a human life." Her comments highlight long-standing criticisms that execution procedures lack transparency and accountability.

Pentobarbital, the drug used in Pike's attempted execution, is a potent sedative that slows the body's nervous system. While doctors sometimes use it to treat certain conditions, in high doses it is employed as a lethal injection. Its use in executions came under renewed scrutiny last year after a federal government review under President Joe Biden raised concerns about the drug's potential for "unnecessary pain and suffering." The federal government subsequently banned its use in federal executions, but that decision did not bind individual states like Tennessee, which retain the authority to choose their own methods.

In recent years, states have struggled to obtain the drugs needed for lethal injections, as pharmaceutical companies have opposed the use of their products for execution purposes. Pike's legal team has alleged that the pentobarbital used in her attempted execution was "degraded," though the Tennessee Department of Correction has not specifically addressed that claim. Drugs can degrade for various reasons, including age beyond their use-by date, which can reduce potency. The department issued a broader defense, stating: "The lethal injection chemical in the protocol has consistently been effective."

This is not the first time Tennessee has encountered problems carrying out an execution in 2026. In May, the execution of Tony Carruthers, convicted of kidnapping and murdering three people in 1994, was postponed after staff could not find a suitable vein to administer the lethal injection. Governor Lee granted him a one-year reprieve. These incidents add to a growing pattern of difficulties in carrying out capital punishment in the state.

Nationally, the issue of botched executions continues to cause alarm. According to the Death Penalty Information Center, more than a third of executions in the United States in 2022 were botched or highly problematic. The organization provides statistics and research on the death penalty but does not take a formal stance on its morality.

Authorities have not said whether they will attempt to execute Pike again. There is historical precedent for states making second attempts to execute death row inmates after initial failures. Meanwhile, Tadaryl Shipp, Pike's boyfriend and co-defendant in the Slemmer murder, remains in prison. He was spared the death penalty under state law because he was 17 years old at the time of the killing.

As Pike remains hospitalized and the state awaits the findings of the governor's review, the case has become a focal point for broader debates about the death penalty's efficacy, humanity, and the secrecy surrounding its implementation. For now, the immediate questions concern Pike's medical condition and whether Tennessee will seek to carry out a second execution attempt—decisions that will unfold in the coming days and weeks.